Safety of Phenylephrine Infusion Through Peripheral Intravenous Catheter in the Neurological Intensive Care Unit

Journal of Intensive Care Medicine

Volumn 33, Issue 10, 2018, Pages 589-592

  Datar, Sudhir ^a   Gutierrez, Eddy ^a   Schertz, Adam ^a   Vachharajani, Vidula ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

neuro ICU; neurocritical care; peripheral catheter; peripheral IV; phenylephrine; vasopressors

Indexed keywords

EPINEPHRINE; HYPERTENSIVE AGENT; NORADRENALIN; PHENYLEPHRINE; VASOCONSTRICTOR AGENT;

AGED; ARTICLE; CONTINUOUS INFUSION; DIABETES MELLITUS; DRUG SAFETY; EXTRAVASATION; FEMALE; HEMATOMA; HOSPITALIZATION; HUMAN; HYPOTENSION; LENGTH OF STAY; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; NEUROLOGICAL INTENSIVE CARE UNIT; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TISSUE INJURY; CATHETERIZATION; DRUG EFFECT; HEMODYNAMICS; INTENSIVE CARE; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CATHETERIZATION, PERIPHERAL; CRITICAL CARE; FEMALE; HEMODYNAMICS; HUMANS; HYPOTENSION; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PHENYLEPHRINE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; VASOCONSTRICTOR AGENTS;

EID: 85041352317     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066617712214     Document Type: Article

References (11)

1. Fugate JE. Complications of neurosurgery. Continuum (Minneap Minn). 2015;21(5 Neurocritical Care):1425–1444
2. Mylonas SN, Moulakakis KG, Antonopoulos CN, Kakisis JD, Liapis CD. Carotid artery stenting-induced hemodynamic instability. J Endovas Ther. 2013;20(1):48–60
3. Treggiari MM. Hemodynamic management of subarachnoid hemorrhage. Neurocrit Care. 2011;15(2):329–335
4. Loubani OM, Green RS. A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters. J Crit Care. 2015;30(3):653.e9-e17
5. Hagley MT, Martin B, Gast P, Traeger SM. Infectious and mechanical complications of central venous catheters placed by percutaneous venipuncture and over guidewires. Crit Care Med. 1992;20(10):1426–1430
6. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003;348(12):1123–1133
7. Eisen LA, Narasimhan M, Berger JS, Mayo PH, Rosen MJ, Schneider RF. Mechanical complications of central venous catheters. J Intensive Care Med. 2006;21(1):40–46
8. Parienti JJ, Mongardon N, Megarbane B. Intravascular complications of central venous catheterization by insertion site. N Engl J Med. 2015;373(13):1220–1229
9. Tisdale JE, Patel RV, Webb CR, Borzak S, Zarowitz BJ. Proarrhythmic effects of intravenous vasopressors. Ann Pharmacother. 1995;29(3):269–281
10. Delgado T, Wolfe B, Davis G, Ansari S. Safety of peripheral administration of phenylephrine in a neurologic intensive care unit: a pilot study. J Crit Care. 2016;34:107–110
11. Cardenas-Garcia J, Schaub KF, Belchikov YG, Narasimhan M, Koenig SJ, Mayo PH. Safety of peripheral intravenous administration of vasoactive medication. J Hosp Med. 2015;10(9):581–585